Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention

Clinical trial NCT06686108 · RECRUITING

Trial details

NCT number: NCT06686108
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Leukemia ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION Relapse

Start date: 2024-10-30
Primary completion: 2027-10-30
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.